| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 口服溶液(元) | 2,321,716.17 | 3,469,865.28 | 2,231,786.62 | 4,202,037.58 | 1,277,675.15 |
| 口服液(元) | 748,000.18 | 1,290,554.32 | 557,342.46 | 3,272,413.25 | 1,972,316.79 |
| 片剂(元) | 4,112,629.21 | 16,111,131.65 | 10,586,030.95 | 14,698,426.00 | 8,090,132.84 |
| 软膏剂(元) | 4,545,816.37 | 14,610,436.74 | 7,495,300.94 | 17,654,437.40 | 7,289,591.37 |
| 原料原料药(元) | 7,720,730.09 | 22,753,853.63 | 14,854,501.45 | 22,812,234.10 | 16,007,519.20 |
| 制剂原料药(元) | 1,636,254.92 | 2,936,794.83 | 1,136,447.44 | 3,019,561.85 | 1,239,557.55 |
| 中间体原料药(元) | 27,292,150.22 | 39,865,201.75 | 10,420,069.01 | 35,028,720.20 | 10,506,550.61 |
| 营业成本(元) | |||||
| 口服溶液(元) | 1,642,298.23 | 1,794,584.07 | 1,232,422.18 | 3,225,856.36 | 1,004,746.20 |
| 口服液(元) | 849,771.01 | 1,360,327.41 | 620,586.44 | 3,270,321.77 | 1,895,391.71 |
| 片剂(元) | 4,150,878.72 | 17,498,623.29 | 11,519,232.03 | 14,616,757.07 | 7,891,125.49 |
| 软膏剂(元) | 1,362,117.61 | 4,016,631.70 | 1,856,010.50 | 4,747,068.53 | 1,809,791.23 |
| 原料原料药(元) | 2,293,961.26 | 8,101,752.81 | 5,273,875.12 | 13,974,524.90 | 9,053,397.95 |
| 制剂原料药(元) | 705,543.69 | 2,382,576.25 | 858,800.98 | 2,191,300.16 | 916,633.92 |
| 中间体原料药(元) | 20,187,972.81 | 38,795,264.46 | 10,116,283.07 | 36,252,532.01 | 11,078,043.92 |
| 毛利(元) | |||||
| 口服溶液(元) | 679,417.94 | 1,675,281.21 | 999,364.44 | 976,181.22 | 272,928.95 |
| 口服液(元) | -101,770.83 | -69,773.09 | -63,243.98 | 2,091.48 | 76,925.08 |
| 片剂(元) | -38,249.51 | -1,387,491.64 | -933,201.08 | 81,668.93 | 199,007.35 |
| 软膏剂(元) | 3,183,698.76 | 10,593,805.04 | 5,639,290.44 | 12,907,368.87 | 5,479,800.14 |
| 原料原料药(元) | 5,426,768.83 | 14,652,100.82 | 9,580,626.33 | 8,837,709.20 | 6,954,121.25 |
| 制剂原料药(元) | 930,711.23 | 554,218.58 | 277,646.46 | 828,261.69 | 322,923.63 |
| 中间体原料药(元) | 7,104,177.41 | 1,069,937.29 | 303,785.94 | -1,223,811.81 | -571,493.31 |
| 毛利率(%) | |||||
| 口服溶液(%) | 29.26 | 48.28 | 44.78 | 23.23 | 21.36 |
| 口服液(%) | -13.61 | -5.41 | -11.35 | 0.06 | 3.90 |
| 片剂(%) | -0.93 | -8.61 | -8.82 | 0.56 | 2.46 |
| 软膏剂(%) | 70.04 | 72.51 | 75.24 | 73.11 | 75.17 |
| 原料原料药(%) | 70.29 | 64.39 | 64.50 | 38.74 | 43.44 |
| 制剂原料药(%) | 56.88 | 18.87 | 24.43 | 27.43 | 26.05 |
| 中间体原料药(%) | 26.03 | 2.68 | 2.92 | -3.49 | -5.44 |
| 收入构成(%) | |||||
| 口服溶液(%) | 4.80 | 3.43 | 4.72 | 4.17 | 2.75 |
| 口服液(%) | 1.55 | 1.28 | 1.18 | 3.25 | 4.25 |
| 片剂(%) | 8.50 | 15.95 | 22.39 | 14.60 | 17.44 |
| 软膏剂(%) | 9.40 | 14.46 | 15.85 | 17.53 | 15.72 |
| 原料原料药(%) | 15.96 | 22.52 | 31.42 | 22.66 | 34.51 |
| 制剂原料药(%) | 3.38 | 2.91 | 2.40 | 3.00 | 2.67 |
| 中间体原料药(%) | 56.42 | 39.46 | 22.04 | 34.79 | 22.65 |
| 毛利构成(%) | |||||
| 口服溶液(%) | 3.95 | 6.18 | 6.32 | 4.36 | 2.14 |
| 口服液(%) | -0.59 | -0.26 | -0.40 | 0.01 | 0.60 |
| 片剂(%) | -0.22 | -5.12 | -5.90 | 0.36 | 1.56 |
| 软膏剂(%) | 18.53 | 39.11 | 35.68 | 57.60 | 43.03 |
| 原料原料药(%) | 31.58 | 54.09 | 60.62 | 39.44 | 54.61 |
| 制剂原料药(%) | 5.42 | 2.05 | 1.76 | 3.70 | 2.54 |
| 中间体原料药(%) | 41.34 | 3.95 | 1.92 | -5.46 | -4.49 |